Kiniksa Pharmaceuticals International (KNSA) Property, Plant & Equipment (Net) Growth (1y) (2018 - 2026)
Kiniksa Pharmaceuticals International (KNSA) Property, Plant & Equipment (Net) Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -18.34% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 6.19% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -0.59% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 41.67% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -7.68% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -1.31% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 3.98% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 3.94% |
| 10 | Kiniksa Pharmaceuticals International | 6.14 Bn | 5.61 Bn | 220.03 Mn | 139.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 139.31% |
| Mar 31, 2026 | 227.72% |
| Dec 31, 2025 | 193.50% |
| Sep 30, 2025 | 195.01% |
| Jun 30, 2025 | 72.16% |
| Mar 31, 2025 | -14.89% |
| Dec 31, 2024 | -9.81% |
| Sep 30, 2024 | -38.89% |
| Jun 30, 2024 | -44.98% |
| Mar 31, 2024 | -48.89% |
| Dec 31, 2023 | -55.73% |
| Sep 30, 2023 | -53.98% |
| Jun 30, 2023 | -47.16% |
| Mar 31, 2023 | -43.72% |
| Dec 31, 2022 | -41.50% |
| Sep 30, 2022 | -37.03% |
| Jun 30, 2022 | -37.66% |
| Mar 31, 2022 | -35.12% |
| Dec 31, 2021 | -30.04% |
| Sep 30, 2021 | -30.72% |